Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jun 16, 2023
Open Peer Review Period: Jun 16, 2023 - Aug 11, 2023
Date Accepted: Jul 21, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
PROMETheus (PReOperative Mitosis Estimator Tool) – An App to Predict Mitotic Count on the Surgical Specimen in GIST
ABSTRACT
Background:
Accurate preoperative risk stratification in Gastrointestinal Stromal Tumors (GISTs) is crucial for determining the need for neoadjuvant therapy. However, existing methods, such as biopsy-based mitotic count assessment, suffer from limitations such as tumor heterogeneity and sampling bias.
Objective:
Our aim was to develop an innovative App that enhances patient stratification accuracy.
Methods:
Utilizing a Bayesian Network as a predictive model, we constructed a Directed Acyclic Graph (DAG) incorporating relevant clinico-pathological variables. Key variables for mitotic count estimation were identified, including tumor size, site, mitotic count on biopsy, surface area assessed on biopsy, and tumor response to therapy (if applicable). The model underwent rigorous testing through prior predictive simulations, validation on a mock dataset, and training on real GIST cases with paired biopsy and surgery (n=80) from IRCCS Humanitas Research Hospital, encompassing a total of 160 cases.
Results:
Our model demonstrated excellent diagnostic performance, with selection based on lower deviance and robust out-of-sample performance. The posterior predictive check further confirmed its accuracy against ground truth. We successfully developed an App that dynamically computes the number of mitoses on the surgical specimen based on tumor size, site, surface area, and mitotic count on biopsy, using posterior probabilities generated by the model.
Conclusions:
Our novel App enables precise prediction of mitotic count on surgical specimens, significantly improving preoperative risk stratification in GISTs. This advancement empowers clinicians to adopt tailored treatment approaches, resulting in enhanced patient outcomes.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.